Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Current Deferred Revenue (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Current Deferred Revenue for 3 consecutive years, with $1.2 million as the latest value for Q4 2022.

  • Quarterly Current Deferred Revenue changed N/A to $1.2 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2022, changed N/A year-over-year, with the annual reading at $1.3 million for FY2022, N/A changed from the prior year.
  • Current Deferred Revenue for Q4 2022 was $1.2 million at NovaBridge Biosciences, up from $1.1 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $2.1 million in Q4 2018, with the low at $1.1 million in Q4 2020.
  • Average Current Deferred Revenue over 3 years is $1.5 million, with a median of $1.2 million recorded in 2022.